Forskningspublikationer som använt U-CAN-material

2011-2016

Nystrom, H et al. Type IV collagen as a tumour marker for colorectal liver metastases. 2011. Eur J Surg Oncol

Nystrom, H et al. Liver-metastatic potential of colorectal cancer is related to the stromal composition of the tumour. 2012. Anticancer Res

Jalkanen, V et al. Indentation loading response of a resonance sensor--discriminating prostate cancer and normal tissue. 2013. J Med Eng Technol

Savary, K et al. Snail depletes the tumorigenic potential of glioblastoma. 2013. Oncogene

Yu, D et al. Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures. 2013. PLoS One

Wee, S et al. Selective calcium sensitivity in immature glioma cancer stem cells. 2014. PLoS One

Babateen, O et al. Etomidate, propofol and diazepam potentiate GABA-evoked GABAA currents in a cell line derived from human glioblastoma. 2015. Eur J Pharmacol

Nyberg, M et al. Dual-modality probe intended for prostate cancer detection combining Raman spectroscopy and tactile resonance technology--discrimination of normal human prostate tissues ex vivo. 2015. J Med Eng Technol

Nystrom, H et al. Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement. 2015. Tumour Biol

Roy, A et al. Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells. 2015. Oncotarget

Saal, L H et al. The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine. 2015. Genome Med

Xie, Y et al. The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes. 2015. EBioMedicine

Abdulla, M et al. A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients. 2016. Acta Oncol

Borssen, M et al. DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia. 2016. Pediatr Blood Cancer

Dahlin, A M et al. Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor. 2016. PLoS One

Frentzas, S et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. 2016. Nat Med

Ghasimi, S et al. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma. 2016. J Neurooncol

Halin Bergstrom, S et al. Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth. 2016. PLoS One

Kundu, S et al. Heparanase Promotes Glioma Progression and Is Inversely Correlated with Patient Survival. 2016. Mol Cancer Res

Ljungstrom, V et al. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations. 2016. Blood

Mansouri, L et al. Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma. 2016. Blood

Segerman, A et al. Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition. 2016. Cell Rep

Truve, K et al. Utilizing the Dog Genome in the Search for Novel Candidate Genes Involved in Glioma Development-Genome Wide Association Mapping followed by Targeted Massive Parallel Sequencing Identifies a Strongly Associated Locus. 2016. PLoS Genet

Wee, B et al. ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells. 2016. Sci Rep

Winter, C et al. Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic. 2016. Ann Oncol

2017-2018

Astrand, A P et al. Prostate Cancer Detection with a Tactile Resonance Sensor-Measurement Considerations and Clinical Setup. 2017. Sensors (Basel)

Degerman, S et al. Maintained memory in aging is associated with young epigenetic age. 2017. Neurobiol Aging

Djusberg, E et al. High levels of the AR-V7 Splice Variant and Co-Amplification of the Golgi Protein Coding YIPF6 in AR Amplified Prostate Cancer Bone Metastases. 2017. Prostate

Hasni, M S et al. Estrogen receptor beta1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker. 2017. Leuk Lymphoma

Jiang, Y et al. Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin. 2017. Cell Rep

Ling, A et al. TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer. 2017. Oncoimmunology

Mathot, L et al. Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer. 2017. Cancer Res

Melin, B S et al. Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. 2017. Nat Genet

Persson, H et al. Frequent miRNA-convergent fusion gene events in breast cancer. 2017. Nat Commun

Thysell, E et al. A Systems Approach to Prostate Cancer Classification-Letter. 2017. Cancer Res

Uhlen, M et al. A pathology atlas of the human cancer transcriptome. 2017. Science

Ylitalo, E B et al. Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response. 2017. Eur Urol

Axelsson, U et al. A multicenter study investigating the molecular fingerprint of psychological resilience in breast cancer patients: study protocol of the SCAN-B resilience study. 2018. BMC Cancer

Bergstrom, S H et al. Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness. 2018. Prostate

Borssen, M et al. DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia. 2018. Clin Epigenetics

Brueffer, C et al. Clinical Value of RNA Sequencing-Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network-Breast Initiative. 2018. JCO Precis Oncol

Enroth, S et al. A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer. 2018. Clin Proteomics

Glimelius, B et al. U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden. 2018. Acta Oncol

Hammarstrom, K et al. Stage distribution utilizing magnetic resonance imaging in an unselected population of primary rectal cancers. 2018. Eur J Surg Oncol

Iglesias-Gato, D et al. The Proteome of Prostate Cancer Bone Metastasis Reveals Heterogeneity with Prognostic Implications. 2018. Clin Cancer Res

Nilsson, M P et al. BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer. 2018. Breast Cancer Res Treat

Norberg, A et al. Novel variants in Nordic patients referred for genetic testing of telomere-related disorders. 2018. Eur J Hum Genet

Pinheiro, T et al. Reprint of: A chemical screen identifies trifluoperazine as an inhibitor of glioblastoma growth. 2018. Biochem Biophys Res Commun

Ryden, L et al. Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative. 2018. Br J Surg

Tjon-Kon-Fat, L A et al. Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients. 2018. Prostate

Trotta, L et al. Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders. 2018. Orphanet J Rare Dis

Vaniotis, G et al. Collagen IV-conveyed signals can regulate chemokine production and promote liver metastasis. 2018. Oncogene

Wikberg, M L et al. Plasma miRNA can detect colorectal cancer, but how early?. 2018. Cancer Med

Wu, C et al. RollFISH achieves robust quantification of single-molecule RNA biomarkers in paraffin-embedded tumor tissue samples. 2018. Commun Biol

2019-2020

Aarnio, R et al. Diagnostic excision of the cervix in women over 40 years with human papilloma virus persistency and normal cytology. 2019. Eur J Obstet Gynecol Reprod Biol X

Adamo, H et al. Prostate cancer induces C/EBPbeta expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome. 2019. Prostate

Amini, R M et al. Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients. 2019. BMC Cancer

Andersson, U et al. The association between longer relative leukocyte telomere length and risk of glioma is independent of the potentially confounding factors allergy, BMI, and smoking. 2019. Cancer Causes Control

Aripaka, K et al. TRAF6 function as a novel co-regulator of Wnt3a target genes in prostate cancer. 2019. EBioMedicine

Barash, U et al. Heparanase promotes glioma progression via enhancing CD24 expression. 2019. Int J Cancer

Berggrund, M et al. Identification of Candidate Plasma Protein Biomarkers for Cervical Cancer Using the Multiplex Proximity Extension Assay. 2019. Mol Cell Proteomics

Biswas, D et al. A clonal expression biomarker associates with lung cancer mortality. 2019. Nat Med

Cancer, M et al. BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells. 2019. Cell Death Dis

Cui, T et al. Invasive cervical tumors with high and low HPV titer represent molecular subgroups with different disease etiology. 2019. Carcinogenesis

Dihge, L et al. Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort. 2019. Clin Cancer Res

Djureinovic, D et al. Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung. 2019. BMC Cancer

Enroth, S et al. High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer. 2019. Commun Biol

Eriksson, M et al. Improved treatment of glioblastoma - changes in survival over two decades at a single regional Centre. 2019. Acta Oncol

Evelonn, E A et al. DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma. 2019. BMC Cancer

Fornvik, D et al. Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment. 2019. Breast Cancer Res Treat

Gustavsson, I et al. Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening. 2019. Virol J

Haider, Z et al. An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression. 2019. Cancer Med

Hammarsten, P et al. Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome. 2019. Mod Pathol

Hammarstrom, K et al. Determining the use of preoperative (chemo)radiotherapy in primary rectal cancer according to national and international guidelines. 2019. Radiother Oncol

Hirvonen, E A M et al. Characterization of an X-chromosome-linked telomere biology disorder in females with DKC1 mutation. 2019. Leukemia

Jimenez-Pascual, A et al. ADAMDEC1 Maintains a Growth Factor Signaling Loop in Cancer Stem Cells. 2019. Cancer Discov

Kolan, S S et al. Growth-inhibition of cell lines derived from B cell lymphomas through antagonism of serotonin receptor signaling. 2019. Sci Rep

Lundgren, C et al. Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer. 2019. Breast Cancer Res Treat

Mezheyeuski, A et al. Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer. 2019. Br J Cancer

Munksgaard Thoren, M et al. Integrin alpha10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival. 2019. Cancers (Basel)

Nilsson, M P et al. High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study. 2019. Breast Cancer Res Treat

Rutegard, M K et al. PET/MRI and PET/CT hybrid imaging of rectal cancer - description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study. 2019. Cancer Imaging

Sjoberg, R L et al. Role of monoamine-oxidase-A-gene variation in the development of glioblastoma in males: a case control study. 2019. J Neurooncol

Sokilde, R et al. Refinement of breast cancer molecular classification by miRNA expression profiles. 2019. BMC Genomics

Staaf, J et al. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. 2019. Nat Med

Strell, C et al. Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ. 2019. J Natl Cancer Inst

Svedlund, J et al. Generation of in situ sequencing based OncoMaps to spatially resolve gene expression profiles of diagnostic and prognostic markers in breast cancer. 2019. EBioMedicine

Thysell, E et al. Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor. 2019. Mol Oncol

Vallon-Christersson, J et al. Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series. 2019. Sci Rep

Wu, W Y et al. The Genetic Architecture of Gliomagenesis-Genetic Risk Variants Linked to Specific Molecular Subtypes. 2019. Cancers (Basel)

Xie, Y et al. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients. 2019. J Pathol

Aarnio, R et al. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study. 2020. BMC Cancer

Abdulla, M et al. Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma. 2020. Eur J Haematol

Abdulla, M et al. Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma. 2020. Am J Hematol

Amini, R M et al. Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome. 2020. Am J Hematol

Andersson-Evelonn, E et al. Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinoma. 2020. J Transl Med

Berggrund, M et al. Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2. 2020. Virol J.

Brueffer, C et al. The mutational landscape of the SCAN-B real-world primary breast cancer transcriptome. 2020. EMBO Mol Med

Drobin, K et al. Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck Cancer. 2020. Cancers (Basel)

Dudka, I et al. Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status. 2020. BMC Cancer

Engvall, M et al. Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics. 2020. BMC Med Genomics

Glimelius, B et al. Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients. 2020. Cancers (Basel)

Glodzik, D et al. Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers. 2020. Nat Commun

Gyllensten, U et al. Preoperative Fasting and General Anaesthesia Alter the Plasma Proteome. 2020. Cancers (Basel).

Haider, Z et al. DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma. 2020. Blood Cancer J

Hammarstrom, K et al. A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer. 2020. Cancers (Basel)

Hikmet, F et al. The protein expression profile of ACE2 in human tissues. 2020. Mol Syst Biol

Jonsson, P et al. Identification of Pre-Diagnostic Metabolic Patterns for Glioma Using Subset Analysis of Matched Repeated Time Points. 2020. Cancers (Basel)

Larsson, C et al. Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer. 2020. NPJ Breast Cancer

Larsson, K et al. Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia. 2020. Growth Factors

Lee, A C et al. OPENchip: an on-chip in situ molecular profiling platform for gene expression analysis and oncogenic mutation detection in single circulating tumour cells. 2020. Lab Chip

Li, X et al. Ex Vivo Organoid Cultures Reveal the Importance of the Tumor Microenvironment for Maintenance of Colorectal Cancer Stem Cells. 2020. Cancers (Basel)

Li, X et al. A Detailed Flow Cytometric Analysis of Immune Activity Profiles in Molecular Subtypes of Colorectal Cancer. 2020. Cancers (Basel)

Lowenmark, T et al. Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer. 2020. Sci Rep

Maturi, N.P. et al. A molecularly distinct subset of glioblastoma requires serum-containing media to establish sustainable bona fide glioblastoma stem cell cultures. 2020. Glia

Menter, T et al. Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy. 2020. Br J Haematol

Miyashita, N et al. ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma. 2020. Cancer Lett

Osterman, E et al. Recurrence Risk after Radical Colorectal Cancer Surgery-Less Than before, But How High Is It?. 2020. Cancers (Basel)

Osterman, E et al. Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort. 2020. Ann Surg Oncol

Quist-Paulsen, P et al. T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol. 2020. Leukemia

Rendo, V et al. Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer. 2020. Sci Rep

Rutegard, M K et al. Rectal cancer: a methodological approach to matching PET/MRI to histopathology. 2020. Cancer Imaging

Sakthikumar, S et al. Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes. 2020. Genome Biol

Voss, G et al. Regulation of cell-cell adhesion in prostate cancer cells by microRNA-96 through upregulation of E-Cadherin and EpCAM. 2020. Carcinogenesis

Ylitalo, E B et al. Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens. 2020. Prostate

2021-2022

Abdulla, M et al. PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS. 2021. Acta Oncol

Aberg, A M et al. High Monocyte Count and Expression of S100A9 and S100A12 in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate Cancer. 2021. Cancers (Basel)

Abu Sabaa, A et al. Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study. 2021. Br J Haematol

Aine, M et al. Molecular analyses of triple-negative breast cancer in the young and elderly. 2021. Breast Cancer Res

Elfving, H et al. Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer. 2021. Lung Cancer

Eltahir, M et al. Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade. 2021. Cancers (Basel)

Ericson Lindquist, K et al. Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines. 2021. J Clin Pathol

Gholiha, A R et al. Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma. 2021. Blood Adv

Gholiha, A R et al. Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue. 2021. Cancers (Basel)

Goldmann, T et al. PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung. 2021. Cancer Immunol Immunother

Gronlund, E et al. Robust treatment planning of dose painting for prostate cancer based on ADC-to-Gleason score mappings - what is the potential to increase the tumor control probability?. 2021. Acta Oncol

Halin Bergstrom, S et al. High-grade tumours promote growth of other less-malignant tumours in the same prostate. 2021. J Pathol

Hidman, J et al. Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma. 2021. Acta Haematol

Imam, I et al. Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery? 2021. Radiother Oncol

Li, X et al. A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry. 2021. Pathol Res Pract

Mattsson Ulfstedt, J et al. Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma. 2021. Ups J Med Sci

Mezheyeuski, A et al. The Immune Landscape of Colorectal Cancer. 2021. Cancers (Basel)

Micke, P et al. The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types. 2021. EBioMedicine

Morth, C et al. Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma. 2021. Cardiooncology

Osterman, E et al. Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer. 2021. Acta Oncol

Rodrigues, J M et al. Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors. 2021. Br J Haematol

Stratmann, S et al. Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets. 2021. Blood Adv

Tebani, A et al. Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis. 2021. Acta Neuropathol Commun

Thysell, E et al. Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C. 2021. Mol Oncol

Ullgren, H et al. Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study. 2021. Acta Oncol

Vajavaara, H et al. Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma. 2021. Haematologica

Ylitalo, E B et al. A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer. 2021. Clin Epigenetics

Zhao, L et al. FACT-seq: profiling histone modifications in formalin-fixed paraffin-embedded samples with low cell numbers. 2021. Nucleic Acids Res

Aasebo, K et al. Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients. 2022. Br J Cancer

Abdulla, M et al. Outcome in PCNSL patients and its association with PD-L1+ leukocytes in the tumor microenvironment. 2022. Acta Oncol

Abu Sabaa, A et al. Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls. 2022. N Biotechnol

Bjorkblom, B et al., Distinct metabolic hallmarks of WHO classified adult glioma subtypes. 2022. Neuro Oncol

Bratulic, S et al. Noninvasive detection of any-stage cancer using free glycosaminoglycans. 2022. Proc Natl Acad Sci U S A

Chen, L et al. Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays. 2022. Nat Commun

Enblad, M et al. Mucinous rectal cancers: clinical features and prognosis in a population-based cohort. 2022. BJS Open

Enroth, S et al. Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment. 2022. Commun Med (Lond)

Gholiha, A R et al. Checkpoint CD47 expression in classical Hodgkin lymphoma. 2022. Br J Haematol

Governa, V et al. Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization. 2022. Proc Natl Acad Sci U S A

Gyllensten, U et al. Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer. 2022. Cancers (Basel)

Hidman, J et al. Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma. 2022. Acta Haematol

Holmgren, K et al. Preoperative biomarkers related to inflammation may identify high-risk anastomoses in colorectal cancer surgery: explorative study. 2022. BJS Open

Lowenmark, T et al. Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer. 2022. Cancer Immunol Immunother

Lowenmark, T et al. Tumour Colonisation of Parvimonas micra Is Associated with Decreased Survival in Colorectal Cancer Patients. 2022. Cancers (Basel)

Lu, X et al. Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival. 2022. Nat Commun

Nie, M et al. The dual role of CD70 in B-cell lymphomagenesis. 2022. Clin Transl Med

Osterlund, E et al. KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer. 2022. Front Oncol

Peglion, F et al. PTEN inhibits AMPK to control collective migration. 2022. Nat Commun

Skaftason, A et al. Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology. 2022. Genes Chromosomes Cancer

Stratmann, S et al. Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children. 2022. Leukemia

Stratmann, S et al. Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression. 2022. Blood Adv

Sundberg, E et al. COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients. 2022. Pediatr Blood Cancer

Wikstrom, P et al. Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy. 2022. Cancers (Basel)

Zhang, H et al. Profiling chromatin accessibility in formalin-fixed paraffin-embedded samples. 2022. Genome Res

2023-2024 (ongoing)

Alvez, M B et al. Next generation pan-cancer blood proteome profiling using proximity extension assay. 2023. Nat Commun

Apollonio, B et al. Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma. 2023. J Clin Invest

Eriksson, A et al. Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia. 2023. Clin Cancer Res

Ginman, B et al. Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2. 2023. Acta Oncol

Ilkhanizadeh, S et al. Live Detection of Neural Progenitors and Glioblastoma Cells by an Oligothiophene Derivative. 2023. ACS Appl Bio Mater

Imam, I et al. Determinants of Pre-Surgical Treatment in Primary Rectal Cancer: A Population-Based Study. 2023 Cancers (Basel)

Jonsdottir, B et al. Advanced gynecological cancer: Quality of life one year after diagnosis. 2023. PLoS One

Kerdreux, M et al. Porphyromonas gingivalis in Colorectal Cancer and its Association to Patient Prognosis. 2023. J Cancer

Kotol, D et al. Absolute Quantification of Pan-Cancer Plasma Proteomes Reveals Unique Signature in Multiple Myeloma. 2023. Cancers (Basel)

Mezheyeuski, A et al. An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers. 2023. EBioMedicine

Nikkarinen, A et al. Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma. 2023. Blood Adv

Pecori, R et al. ADAR1-mediated RNA editing promotes B cell lymphomagenesis. 2023. iScience

Sjoholm, T et al. A whole-body diffusion MRI normal atlas: development, evaluation and initial use. 2023. Cancer Imaging

Spyratou, V et al. Ki67 and prostate specific antigen are prognostic in metastatic hormone naive prostate cancer. 2023. Acta Oncol

Stratmann, S et al. Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children. 2023. Leukemia

Vikman, S et al. Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia. 2023. Ups J Med Sci

Edin, S et al. Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy. 2024. Br J Cancer

Grahn, O et al. Mutation of the cyclooxygenase 2 gene promoter and anastomotic leakage in colorectal cancer patients: retrospective cohort study. 2024. BJS Open

Ren, W et al. Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. 2024. Leukemia

Rodrigues, J.M et al. MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 - a Nordic Lymphoma Group study. 2024. Haematologica

Sandberg, E et al. Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma. 2024. Cancers (Basel)